Roche Invalidates Competitor's Insulin Pump IP In UK Suit

Law360, London (July 13, 2021, 6:54 PM BST) -- A judge handed a two-part win to Roche in an intellectual property dispute brought by a rival insulin pump maker, saying the pharmaceutical giant's device didn't infringe on Insulet's patent while invalidating the patent for being divulged by an earlier invention.

Pat Treacy, sitting as a judge of the High Court, concluded Friday that Insulet's remote-controlled patch pump for the treatment of diabetes lacked an inventive step because the idea was disclosed in a 2000 patent application titled "PhiScience."

The judge also found that Roche Diabetes Care's Accu-Chek Solo micropump system didn't copy Insulet's invention either directly or by being significantly...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!